[Federal Register Volume 63, Number 196 (Friday, October 9, 1998)]
[Notices]
[Pages 54490-54491]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-27100]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 5, 1998, Ansys 
Diagnostics, Inc., 25200 Commercentre Drive, Lake Forest, California 
92630, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phencyclidine (7471)........................  II
1-Piperidinocyclohexanecarbonitrile (PCC)     II
 (8603).
Benzoylecgonine (9180)......................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
produce standards and controls for in-vitro diagnostic drug testing 
systems.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than December 8, 1998.


[[Page 54491]]


    Dated: October 1, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement Administration.
[FR Doc. 98-27100 Filed 10-8-98; 8:45 am]
BILLING CODE 4410-09-M